sumi.news
Search
Following
Sign in
← Back to news
Y
Yahoo Finance
RSS Feed
finance.yahoo.com
finance.yahoo.com/rss
Follow
Latest
Sun Mar 29
UPS to close 27 additional parcel facilities in 2026
6h
Y
Humana Q1 2026 earnings beat estimates, stock falls
6h
Y
Amazon Earnings Preview: AI Momentum In Focus, But This Number Could Be 'Messy'
6h
Y
T-Mobile Shoots Down Cable TV Acquisition On Q1 Earnings Call
6h
Y
Verizon Communications vs. AT&T: What's the Better Dividend Stock to Buy Right Now?
6h
Y
Avis Plummets 12%, Hertz Drops 5% – What’s Going On With Car Rental Stocks?
6h
Y
Mondelez “cautiously optimistic” as outlook rests on consumer uncertainty
6h
Y
John Fetterman's Micron Stock Bet Surges 61%, Notes Popular Nancy Pelosi Tracker: 'This Is Suspect'
6h
Y
Starbucks Leads Seven Stocks Flashing Buy Signals On Earnings
6h
Y
Visa earnings top estimates on strong spending, shares rise
6h
Y
KKR & Co. (KKR) Falls on Earnings Miss Despite Strong Fundraising Momentum and Long-Term Growth Plans
6h
Y
The freight brokerage model broke carrier selection
6h
Y
Kone agrees to buy TK Elevator for $34.4 billion
6h
Y
Silicon Motion Stock Rockets As Sales More Than Double
6h
Y
Galaxy Digital Leads Investment In Blockchain Startup Fence
6h
Y
Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide
6h
Y
What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in
6h
Y
Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial
6h
Y
H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)
6h
Y
Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why
6h
Y
Ocular Therapeutix Inc. (OCUL) Appears Highly Attractive Following SOL-1 Clinical Trial Data
6h
Y
Here is Why Structure Therapeutics (GPCR) is One of the Top Biotech Names to Look at
6h
Y
Do You Believe in The Long-Term Growth Outlook of Thermo Fisher Scientific (TMO)?
6h
Y
In A Victory, Gemini Put In Four Million GM Cars
6h
Y
AbbVie beats Q1 2026 earnings, raises full-year forecast
6h
Y
Ex-Mars CEO named Lipton chair
6h
Y
Robinhood's crypto revenue tanks 47%, gap filled by prediction markets
6h
Y
Regeneron Slumps On An Unexpected Setback For Its Bread-And-Butter Drug
6h
Y
Eli Lilly and Company (LLY) Declined in Q1 Despite Strong Results
6h
Y
Seagate Stock Soars After AI Demand Powers Big Earnings Beat
6h
Y
Lululemon Founder Takes Aim at New CEO Pick, Escalates Proxy Fight
6h
Y
Treasury Yields Keep Rising as Oil Prices Spur Inflation Fears
6h
Y
Should You Be Bullish on Natera (NTRA)?
6h
Y
Why data storage stocks are a key AI play
6h
Y
Fed meeting today: Central bank 'firmly parked' on interest rate pause
6h
Y
Teva Surges 10% — And It's Not Completely Tied To Earnings
6h
Y
'Did I save too much?': Your 401(k) may be at all-time highs, but big balances carry hidden retirement risks
7h
Y
Meta Earnings Preview: AI 'Monetization Story' Faces Biggest Test Yet
7h
Y
Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1
7h
Y
Daily – Vickers Top Insider Picks for 04/29/2026
7h
Y
Daily – Vickers Top Buyers & Sellers for 04/29/2026
7h
Y
German, Spanish Inflation Reach Multiyear Highs
7h
Y
What Makes Rollins (ROL) an Attractive Investment?
7h
Y
Polen Focus Growth Bets on Lam Research (LRCX), a Critical Supplier of Etch and Deposition Equipment
7h
Y
AbbVie Flails As 'Negative Sentiment' Persists Despite Immunology Beat
7h
Y
Here’s What Pressured CoStar Group (CSGP) in Q1
7h
Y
C3 Metals continues to define copper resource at Khaleesi project with latest drill results
7h
Y
Yum China Q1 Earnings Call Highlights
7h
Y
Veralto Q1 Earnings Call Highlights
7h
Y
Fannie Mae Q1 Earnings Call Highlights
7h
Y
More →